Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Bridge Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Bridge Therapeutics

Bridge Therapeutics

Series A

Bridge Therapeutics: A specialty pharma company focused on chronic pain and opioid addiction solutions.

HQ
Birmingham, AL, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Bridge Therapeutics, founded with the mission to improve healthcare for millions suffering from chronic pain and opioid addiction, is a specialty pharmaceutical company. The company focuses on developing safer and more effective therapies for opioid use disorder (OUD) and chronic pain management. Their key products include BT, a novel delivery system for buprenorphine-naloxone aimed at treating OUD, and BT-, a patented drug combination designed for chronic pain in opioid-experienced patients.

Notable figures affiliated with Bridge Therapeutics include experts in pharmaceutical development and pain management. The company has achieved significant milestones, including securing U.S. patents for their innovative drug combinations. By pursuing FDA approval for their therapies, Bridge Therapeutics aims to make a substantial impact on the opioid crisis, offering new hope to patients and healthcare providers dealing with the complexities of pain and addiction.

Bridge Therapeutics - Similar Companies

Bridge Medicines logo

Bridge Medicines

Braeburn logo

Braeburn

braeburnrx.com

Bridge Pharmaceuticals logo

Bridge Pharmaceuticals

Latigo Biotherapeutics logo

Latigo Biotherapeutics

latigobio.com

Aether Therapeutics logo

Aether Therapeutics

BridgeBio Pharma logo

BridgeBio Pharma

bridgebio.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Elite Pharmaceuticals logo

Elite Pharmaceuticals

elitepharma.com

LifeBridge Innovations logo

LifeBridge Innovations

BridGene Biosciences logo

BridGene Biosciences

Concentric Analgesics logo

Concentric Analgesics

Solace Pharmaceuticals logo

Solace Pharmaceuticals

Centrexion Therapeutics logo

Centrexion Therapeutics

Bluejay Therapeutics logo

Bluejay Therapeutics

bluejaytx.com

Amalgent Therapeutics logo

Amalgent Therapeutics

amalgent.com

Bridge Therapeutics - Quick Facts

Who are Bridge Therapeutics' competitors?

Companies similar to Bridge Therapeutics include Bridge Medicines, Braeburn, Bridge Pharmaceuticals and Latigo Biotherapeutics.

When was Bridge Therapeutics founded?

Bridge Therapeutics was founded in 2016.

Where is Bridge Therapeutics' headquarters located?

Bridge Therapeutics' headquarters is located in Birmingham, AL, US.

When was Bridge Therapeutics' last funding round?

Bridge Therapeutics' most recent funding round was for $3M (USD) in April 2019.

How much has Bridge Therapeutics raised to-date?

As of Apr 24, 2019, Bridge Therapeutics has raised a total of $4M (USD).

How many employees does Bridge Therapeutics have?

Bridge Therapeutics has 9 employees as of Feb 4, 2024.

Bridge Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified